Immunohistochemistry showed that there were no significant differences in CD44 expression between ccRCC and non-ccRCC cases, while MMP-2 and MMP-9 were more expressed in non-ccRCC cases. The gene discussed is MMP2; the disease is nonpapillary renal cell carcinoma.